EXORPHIA Joins Council to Promote Cutting-Edge Fertility Treatment Technologies

EXORPHIA's Significant Step in Fertility Treatment

On March 4, 2026, EXORPHIA, a company based in Tokyo and led by President Koji Kuchiishi, announced its participation in the Fertility Treatment Technology Council. This organization aims to foster the dissemination of advanced fertility technologies and promote the growth of the industry. Through this collaboration, EXORPHIA is committed to addressing challenges in the implementation and commercialization of cutting-edge technologies in the arena of fertility treatment.

The State of Fertility Treatments

While Japan holds a reputation for high medical standards in fertility treatments, several issues remain regarding the social implementation of advanced technologies. EXORPHIA employs the latest biotechnologies to tackle the bottlenecks associated with Assisted Reproductive Technology (ART). By joining this council, the company aligns itself with initiatives that encourage cooperation among relevant government agencies, academic societies, medical institutions, and other organizations to push forward proposals and advancements in reproductive medicine.

A Commitment to Patients and Technology

As part of its vision, EXORPHIA aims to ensure that necessary medical technologies are delivered efficiently to patients. The company places great importance on creating an environment conducive to the proper implementation of evidence-based technology in reproductive healthcare. Through participation in the Fertility Technology Council, EXORPHIA will contribute actively to promoting innovative medical practices that can positively impact patient care.

Comments from EXORPHIA’s President

Koji Kuchiishi, President of EXORPHIA, stated, "The challenges of fertility treatments cannot be resolved solely through the efforts of the medical field; collaboration among systems, implementation, and industry is essential. Our commitment to using biotechnology to resolve bottlenecks in ART, alongside discussions and partnerships through this council, will facilitate the optimal provision of essential medical technologies tailored to patients' needs."

About the Fertility Treatment Technology Council

The Fertility Treatment Technology Council is dedicated to promoting the proliferation of advanced technologies in fertility treatments. The organization works in coordination with government ministries, academic societies, healthcare institutions, businesses, and other entities to drive discussions and policy proposals aimed at fostering growth within this field. Further information can be accessed through their official website: Fertility Tech Japan

More About EXORPHIA

EXORPHIA employs cutting-edge biotechnology to address issues and implement solutions within the field of reproductive medicine. The company's innovative approach reflects its dedication to improving medical practices and patient outcomes.